Literature DB >> 10835680

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.

S D Yan1, H Zhu, A Zhu, A Golabek, H Du, A Roher, J Yu, C Soto, A M Schmidt, D Stern, M Kindy.   

Abstract

Accumulation of fibrils composed of amyloid A in tissues resulting in displacement of normal structures and cellular dysfunction is the characteristic feature of systemic amyloidoses. Here we show that RAGE, a multiligand immunoglobulin superfamily cell surface molecule, is a receptor for the amyloidogenic form of serum amyloid A. Interactions between RAGE and amyloid A induced cellular perturbation. In a mouse model, amyloid A accumulation, evidence of cell stress and expression of RAGE were closely linked. Antagonizing RAGE suppressed cell stress and amyloid deposition in mouse spleens. These data indicate that RAGE is a potential target for inhibiting accumulation of amyloid A and for limiting cellular dysfunction induced by amyloid A.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835680     DOI: 10.1038/76216

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  80 in total

Review 1.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

Authors:  A M Schmidt; S D Yan; S F Yan; D M Stern
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

2.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 3.  Primary tracheobronchial amyloidosis in China: analysis of 64 cases and a review of literature.

Authors:  Liren Ding; Wen Li; Kai Wang; Yahong Chen; Hao Xu; Huiying Wang; Huahao Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

4.  Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.

Authors:  Mingjie Chen; Huibing Zhou; Ni Cheng; Feng Qian; Richard D Ye
Journal:  Immunobiology       Date:  2014-08-10       Impact factor: 3.144

5.  Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia.

Authors:  Jin Yu; Hong Zhu; Saeid Taheri; William Mondy; Leonardo Bonilha; Gayenell S Magwood; Daniel Lackland; Robert J Adams; Mark S Kindy
Journal:  J Neurosci       Date:  2019-10-14       Impact factor: 6.167

Review 6.  Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

7.  Significant modifications of the salivary proteome potentially associated with complications of Down syndrome revealed by top-down proteomics.

Authors:  Tiziana Cabras; Elisabetta Pisano; Caterina Montaldo; Maria Rita Giuca; Federica Iavarone; Giuseppe Zampino; Massimo Castagnola; Irene Messana
Journal:  Mol Cell Proteomics       Date:  2013-03-26       Impact factor: 5.911

Review 8.  Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

9.  Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases.

Authors:  Lih-Fen Lue; Douglas Gordon Walker; Sandra Jacobson; Marwan Sabbagh
Journal:  Future Neurol       Date:  2009

10.  HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin.

Authors:  Ibolya E András; Sung Yong Eum; Wen Huang; Yu Zhong; Bernhard Hennig; Michal Toborek
Journal:  Mol Cell Neurosci       Date:  2009-11-26       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.